MedTrace Logo

Safety and Feasibility Study of Robotic Assisted Transanal Total Mesorectal Excision for Rectal Cancer

NCT04573738 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2023-11-27

No results posted yet for this study

Summary

Total mesorectal excision has greatly reduced the local recurrence rate of rectal cancer after colorectal surgery. Transanal total mesorectal excision(TaTME) is potentially a suitable option for patients with middle and low rectal cancer. Robotic systems are expected to develop the advantages of TaTME to overcome the limitations of laparoscopic surgery. This study aimed to investigate the safety and feasibility of robotic assisted transanal total mesorectal excision in patients with rectal cancer.

Conditions

Interventions

PROCEDURE

Robotic assisted transanal total mesorectal excision

Robotic assisted transanal total mesorectal excision for rectal cancer patients

PROCEDURE

Laparoscopic assisted transanal total mesorectal excision

Laparoscopic assisted transanal total mesorectal excision for rectal cancer patients

Sponsors & Collaborators

  • Third Military Medical University

    lead OTHER

Principal Investigators

  • Weidong Tong, MD · Army Military Medical University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-01
Primary Completion
2020-05-31
Completion
2021-09-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04573738 on ClinicalTrials.gov